Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Mirault, M.E., Tremblay, A., Beaudoin, N
No agitar
This results in a decrease in appetite and changes in taste, and causes users to change the way they eat
Important safety information includes a boxed warning for risk of thyroid C-cell tumors, with contraindications in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Lancet 390(10103):16641675 Athauda D, Gulyani S, Kumar Karnati H et al (2019) Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide-PD trial